Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha 1-Antitrypsin | 9 | 2026 | 97 | 2.370 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 5 | 2026 | 72 | 1.550 |
Why?
|
| Genetic Therapy | 8 | 2026 | 836 | 1.120 |
Why?
|
| Dependovirus | 8 | 2026 | 746 | 1.020 |
Why?
|
| Genetic Vectors | 8 | 2026 | 918 | 0.980 |
Why?
|
| Gene Expression | 3 | 2026 | 867 | 0.800 |
Why?
|
| Hepatocytes | 3 | 2020 | 225 | 0.700 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2023 | 460 | 0.650 |
Why?
|
| Transgenes | 2 | 2026 | 199 | 0.350 |
Why?
|
| Liver | 4 | 2026 | 878 | 0.280 |
Why?
|
| Mice | 10 | 2026 | 11209 | 0.250 |
Why?
|
| Mice, Transgenic | 5 | 2025 | 1308 | 0.230 |
Why?
|
| Gene Editing | 3 | 2025 | 333 | 0.220 |
Why?
|
| Liver Diseases | 1 | 2025 | 160 | 0.210 |
Why?
|
| Primates | 1 | 2024 | 54 | 0.210 |
Why?
|
| Lung Diseases | 1 | 2025 | 183 | 0.200 |
Why?
|
| Animals | 11 | 2026 | 21533 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 1 | 2026 | 697 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2294 | 0.180 |
Why?
|
| Transplantation, Heterologous | 2 | 2020 | 243 | 0.180 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 528 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 376 | 0.150 |
Why?
|
| Mice, SCID | 1 | 2020 | 523 | 0.140 |
Why?
|
| Alleles | 1 | 2020 | 457 | 0.140 |
Why?
|
| Enzyme Assays | 1 | 2017 | 15 | 0.130 |
Why?
|
| Reference Standards | 1 | 2017 | 77 | 0.130 |
Why?
|
| Humans | 11 | 2026 | 65554 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2020 | 2149 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2015 | 245 | 0.120 |
Why?
|
| Gene Silencing | 2 | 2017 | 421 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 311 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 593 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2012 | 14 | 0.090 |
Why?
|
| Mitochondrial Diseases | 1 | 2012 | 22 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2012 | 51 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 327 | 0.080 |
Why?
|
| Mutation | 4 | 2025 | 2688 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2009 | 38 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2017 | 711 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2009 | 84 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2009 | 71 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2009 | 102 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 801 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1172 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 766 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 36 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 53 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2024 | 619 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 117 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 461 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 325 | 0.040 |
Why?
|
| Graft Survival | 1 | 2017 | 298 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2700 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 172 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2015 | 106 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 263 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 378 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2012 | 9 | 0.020 |
Why?
|
| Carnitine | 1 | 2012 | 21 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 34 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 295 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 207 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Male | 2 | 2024 | 31083 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 228 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 19 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 98 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1346 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 151 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 133 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 1241 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 674 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1638 | 0.010 |
Why?
|